Onconova Therapeutics Inc...

NASDAQ: ONTX · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Apr 02, 2024, 10:00 PM

Onconova Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.00 -0.83 -0.74 -2.71
PEG Ratio
-0.00 -0.36 0.12 0.05
PS Ratio
0.00 69.24 60.13 189.92
PB Ratio
-0.00 1.47 0.48 0.93
P/FCF Ratio
-0.00 -0.87 -0.83 -2.2
P/OCF Ratio
-0.00 -0.87 -0.83 -2.2
OCF/S Ratio
-131.82 -79.35 -72.1 -86.23
Debt / Equity Ratio
n/a n/a n/a n/a
Quick Ratio
2.16 2.30 4.88 9.06
Current Ratio
2.16 2.46 4.89 9.06
Asset Turnover
0.01 0.01 0.01 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
5.26 -1.78 -0.65 -0.34
Return on Assets
-6.67 -0.84 -0.46 -0.29
Return on Invested Capital
-10.6 n/a -0.6 -0.33
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-518.75 1M 0.94 0.94
Net Profit Margin
-736.83 -83.84 -80.98 -70.04
Pretax Profit Margin
-736.83 -83.84 -83.91 -71.52
Operating Profit Margin
-629.97 -89.81 -86.85 -72.99
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-629.97 -89.74 -86.85 -74.41